Galafold 123 MG
Ended Awarded Last action
- Contract number
- 36C24526N0706
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $22,840
Award facts
- Contract value 100% obligated
- $22,839.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
Veterans Integrated Service Network 5 issued a $22,839.61 delivery order to Amicus Therapeutics US, LLC on July 1, 2026, for Galafold (migalastat) 123 mg under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
Place of performance is Philadelphia, PA 19104. The order is due July 7, 2026. The requirement is for Galafold 123 mg capsules, an FDA-approved enzyme replacement therapy indicated for treatment of Fabry disease in veterans. Pricing is firm fixed price with no set-aside. Amicus Therapeutics US, LLC performs as prime contractor with no subcontractor involvement. The parent FSS contract, valued at $13.024 million, is effective through August 31, 2029, and enables VISNs across the Veterans Health Administration to place task orders for this specialized pharmaceutical product.
Quick answers
Who was awarded contract 36C24526N0706?
36C24526N0706 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on July 1, 2026.
How much is contract 36C24526N0706 worth?
The government has obligated $22,840 on 36C24526N0706.
Is contract 36C24526N0706 an order under another contract?
Yes. 36C24526N0706 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0706 competed?
The extent of competition for 36C24526N0706 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award